Funds · 13F filer · Menlo Park, CA

Nvp Associates, LLC

$328.2M in 7 U.S. stocks and ETFs at the end of June 30, 2026, as reported to the SEC.1

1y return+116.2%S&P 500 +20.9%

These returns are for its stock picks as disclosed on Form 13F: last quarter's holdings, valued at this quarter's prices. They miss trades within each quarter, short positions, options, bonds, cash and fees, so they aren't the returns its clients got.

$100 invested in its stock picks

Since June 30, 2025: $216 against $121 in the S&P 500.2

Nvp Associates, LLCS&P 500 (SPY)
$100$21620252026

Top holdings

At the end of June 30, 2026. Change is in shares since the quarter before.2

StockValueShare of portfolioChange
MBXMbx Biosciences Inc$117.9M35.9%
AVLNAvalyn Pharmaceuticals Inc$74.7M22.8%New
OMDAOmada Health Inc$55.6M16.9%
ZBIOZenas Biopharma Inc$46.7M14.2%
SNOWSnowflake Inc$29.2M8.9%New
GROVGrove Collaborative Hold Inc$4.0M1.2%
ONDSOndas Inc$129K0.0%New

Best picks still held

How each current holding has done since the quarter it first appeared in its filings (up to six years back).

StockHeld sinceReturn sinceNow worth
MBXMbx Biosciences IncSeptember 30, 2024+112.5%$117.9M
ZBIOZenas Biopharma IncSeptember 30, 2024+50.0%$46.7M
OMDAOmada Health IncJune 30, 2025+19.9%$55.6M
GROVGrove Collaborative Hold IncJune 30, 2023−29.4%$4.0M

Sold off last quarter

  • BLLNBilliontoone Inc was $40.5M

Quarter by quarter

QuarterIts picksS&P 500
June 30, 2026+62.2%+14.8%
March 31, 2026−11.1%−4.6%
December 31, 2025+28.4%+2.4%
September 30, 2025+16.8%+7.8%
March 31, 2025−20.6%−4.6%
December 31, 2024+6.1%+2.1%
September 30, 2024−1.9%+5.4%
June 30, 2024−27.5%+4.0%
March 31, 2024−2.7%+10.0%
December 31, 2023+43.1%+11.2%
September 30, 2023−2.5%−3.6%
June 30, 2023+31.8%+8.3%
March 31, 2023−14.0%+7.0%

Sources

Every number on this page points here. Each one links to the public record.

  1. 1
    CIK 1545692
  2. 2
    Filed August 7, 2026 · accession 0001545692-26-000009